US trial of opioid drug makers’ starts over 500,000 overdose deaths

Organisation: Position: Deadline Date: Location:

Four drugmakers, including Johnson & Johnson and Teva Pharmaceutical Industries Ltd have gone to trial over claims they helped fuel an opioid crisis that has resulted in nearly 500,000 overdose deaths in the US, reports Reuters. The trial is one of several looking to hold companies accountable for the overdose and abuse crisis that are set to take place this year after the coronavirus pandemic delayed litigation, putting renewed pressure on them to enter into multi-billion-dollar settlements.

J&J, Teva Pharmaceutical Industries Ltd, Endo International PLC and Abbvies Allergan unit are accused by several California counties of deceptively marketing painkillers in ways that downplayed their addictive risks to boost sales.

If the companies are held liable by Orange County Superior Court Judge Peter Wilson following a trial conducted virtually, the counties say they should have to pay $50bn to help foot the costs of abating the public nuisance they created plus penalties.

J&J in a statement called its marketing of the drugs “appropriate and responsible,” Israel-based Teva said it will defend itself against these “unproven allegations.” Endo and Allergan declined to comment.

Reuters reports that more than 3,400 lawsuits brought largely by states and local governments are pending against companies accused of fuelling the opioid epidemic.

 

Full Reuters report (Open access)


Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.